SHORT-TERM EFFICACY AND SAFETY OF ABROCITINIB BY BASELINE DISEASE SEVERITY IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

被引：0

作者：

Rice, Zakiya P. ^{[1
]}

Gooderham, Melinda J. ^{[2
,3
]}

Lebwohl, Mark G. ^{[4
]}

Simpson, Eric L. ^{[5
]}

Boguniewicz, Mark ^{[6
,7
]}

Wollenberg, Andreas ^{[8
]}

Lazariciu, Irina ^{[9
]}

Chan, Gary L. ^{[10
]}

Alderfer, Justine ^{[11
]}

Watkins, Melissa ^{[12
]}

机构：

[1] Dermatol Associates Georgia, Atlanta, GA USA

[2] Queens Univ, SKiN Ctr Dermatol, Peterborough, ON, Canada

[3] Prob Med Res, Peterborough, ON, Canada

[4] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[5] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA

[6] Natl Jewish Hlth, Dept Pediat, Denver, CO USA

[7] Univ Colorado, Sch Med, Denver, CO USA

[8] Ludwig Maximilians Univ Munchen, Pediat Dermatol, Dermatol & Venerol, Munich, Germany

[9] IQVIA, Dept Biostat, Quebec City, PQ, Canada

[10] Pfizer Inc, Groton, CT 06340 USA

[11] Pfizer Inc, Collegeville, PA USA

[12] Pfizer Inc, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P4.09

引用

页码：30 / 30

页数：1